Enterprise League logo
Hudson Therapeutics, US Subsidiary of Shaperon Logo

Hudson Therapeutics, US Subsidiary of Shaperon

Durham, United States (US) · Health and Medical

Do your work at Hudson Therapeutics, US Subsidiary of Shaperon?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

Last verified

May 2026

Overview

Hudson Therapeutics, US Subsidiary of Shaperon is a clinical-stage biotechnology company based in Durham, North Carolina, focused on developing innovative drugs for inflammatory and immunological diseases.

Founded in February 2023 by Shaperon Inc., a KOSDAQ-listed biotech in Korea, and led by Dr. Shawn Y. Seong, Hudson Therapeutics, Inc. leverages a strategic approach to enhance therapeutic potential.

Our core strategy involves in-licensing promising assets, adding value through innovative development, and ultimately out-licensing them to maximize their commercialization. We are dedicated to enriching patients’ quality of life through advancements in anti-inflammatory and immunology therapies.

Most teams do this before shortlisting


Contact Details

+1919-300-4927
peoples@hudsontherapeutics.com

Durham, United States (US), 600 Park Office Dr

Founded

2023

Company Type

Public Limited Company

Employees

2-10

Keywords

#biotechnology

#anti-inflammatory

#immunology

#atopic dermatitis

#inflammasome inhibitor

#alzheimer

#orphan disease

#nanobody

Companies teams usually look at after Hudson Therapeutics, US Subsidiary of Shaperon

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.